Speaker illustration

Associate Professor Bing Wang

Monash University, Melbourne (Australia)

VCP979, a novel p38MAPK inhibitor, attenuates inflammatory response and improve cardiac function post-myocardial infarction

Event: ESC Congress 2017

Topic: Pharmacologic therapy

Session: Chronic heart failure (CHF)


Sphingolipid targeting agent MIPS247 attenuates collagen synthesis by cardiac and kidney cells via stabilization of PPM1A

Event: ESC Congress 2016

Topic: Basic mechanisms

Session: Heart failure/Left ventricular function


ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb